Amit Baumel1, Christoph U Correll1, Marta Hauser1, Mary Brunette1, Armando Rotondi1, Dror Ben-Zeev1, Jennifer D Gottlieb1, Kim T Mueser1, Eric D Achtyes1, Nina R Schooler1, Delbert G Robinson1, Susan Gingerich1, Patricia Marcy1, Piper Meyer-Kalos1, John M Kane1. 1. Dr. Baumel, Dr. Correll, Dr. Hauser, Dr. Schooler, Dr. Robinson, Ms. Marcy, and Dr. Kane are with the Department of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York (e-mail: abaumel@northwell.edu ). Dr. Baumel, Dr. Correll, Dr. Robinson, and Dr. Kane are also with Hofstra Northwell School of Medicine, Hempstead, New York. Dr. Hauser and Ms. Marcy are also with the Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, New York. Dr. Schooler is also with the Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Brunette and Dr. Ben-Zeev are with the Center for Technology and Behavioral Health, Dartmouth Psychiatric Research Center, Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire. Dr. Rotondi is with the Department of Critical Care Medicine, Clinical and Translational Sciences Institute, Pittsburgh, and with the Mental Illness Research, Education and Clinical Center, U.S. Department of Veterans Affairs Medical Center, Pittsburgh. Dr. Gottlieb and Dr. Mueser are with the Center for Psychiatric Rehabilitation, Boston University, Boston. Dr. Achtyes is with Cherry Health and Michigan State University College of Human Medicine, East Lansing. Ms. Gingerich is an independent consultant and trainer in Narberth, Pennsylvania. Dr. Meyer-Kalos is with the Department of Social Work, Minnesota Center for Chemical and Mental Health, St. Paul.
Abstract
OBJECTIVE: The authors examined patients' acceptance of the Health Technology Program (HTP), an integrative approach to relapse prevention after hospitalization of adults with schizophrenia or related disorders. The program combines use of digital tools with support from a mental health technology coach (MHTC). METHODS: Patients with schizophrenia spectrum disorders received six months of treatment that began within 60 days of a psychiatric hospitalization and included the development of a personalized relapse prevention plan, three digital tools, and contacts with MHTCs. RESULTS: A total of 200 patients (mean±SD age=34.6±10.6 years) had 28.2±2.0 contacts with the MHTC that lasted 38.3±14.2 minutes. The most discussed topic was case management (52%), and digital tools were discussed in 45% of meetings. Altogether, 87% of patients used at least one of the digital tools, with 96% of patients rating the HTP as satisfying to at least some extent. CONCLUSIONS: These data suggest very high acceptance of the HTP, a program that integrates available human support with digital tools.
OBJECTIVE: The authors examined patients' acceptance of the Health Technology Program (HTP), an integrative approach to relapse prevention after hospitalization of adults with schizophrenia or related disorders. The program combines use of digital tools with support from a mental health technology coach (MHTC). METHODS:Patients with schizophrenia spectrum disorders received six months of treatment that began within 60 days of a psychiatric hospitalization and included the development of a personalized relapse prevention plan, three digital tools, and contacts with MHTCs. RESULTS: A total of 200 patients (mean±SD age=34.6±10.6 years) had 28.2±2.0 contacts with the MHTC that lasted 38.3±14.2 minutes. The most discussed topic was case management (52%), and digital tools were discussed in 45% of meetings. Altogether, 87% of patients used at least one of the digital tools, with 96% of patients rating the HTP as satisfying to at least some extent. CONCLUSIONS: These data suggest very high acceptance of the HTP, a program that integrates available human support with digital tools.
Authors: Neil Thomas; Josef J Bless; Ben Alderson-Day; Imogen H Bell; Matteo Cella; Tom Craig; Philippe Delespaul; Kenneth Hugdahl; Julien Laloyaux; Frank Larøi; Tania M Lincoln; Björn Schlier; Prabitha Urwyler; David van den Berg; Renaud Jardri Journal: Schizophr Bull Date: 2019-02-01 Impact factor: 9.306
Authors: Dror Ben-Zeev; Emily A Scherer; Jennifer D Gottlieb; Armando J Rotondi; Mary F Brunette; Eric D Achtyes; Kim T Mueser; Susan Gingerich; Christopher J Brenner; Mark Begale; David C Mohr; Nina Schooler; Patricia Marcy; Delbert G Robinson; John M Kane Journal: JMIR Ment Health Date: 2016-07-27